ISRCTN11442263已完成3 期
A multi-centre randomised controlled trial examining the effects of temporarily suspending low-dose methotrexate treatment for two weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions, including a nested mechanistic sub-study
CTU03730 个研究点目标入组 383 人开始时间: 2021年8月23日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 383
研究概览
简要总结
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35504634/ (added 04/05/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35772416/ (added 01/07/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38267107/ (added 25/01/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged =18 years
- •2. Diagnosed with inflammatory conditions such as rheumatoid arthritis, psoriasis with or without arthritis, seronegative spondyloarthritis, reactive arthritis, atopic eczema, polymyalgia rheumatica, or systemic lupus erythematosus. This is not an exhaustive list and people with other inflammatory conditions where treatment may be interrupted for two weeks without the risk of a substantial increase in disease activity, or organ or life-threatening flare up will also be eligible to participate in the study in order to increase the generalisability of the study.
- •3. Prescribed with oral or subcutaneous methotrexate (=25 mg/week) +/- hydroxychloroquine weekly administered for at least the previous three months
- •4. Able to temporarily suspend methotrexate for two weeks in the opinion of patients’ consultant without the risk of substantial increase in disease activity, or organ or life-threatening flare-up
- •5. Able to give informed consent;
- •6. Eligible for planned booster vaccination for COVID-19 (i.e. have received any 2 vaccinations from the original NHS COVID Vaccination Programme 2020/21)
排除标准
- •Current participant exclusion criteria as of 08/03/2022:
- •1. Diagnosed with any of: ANCA associated vasculitis, large vessel vasculitis, myositis, giant cell arteritis, solid organ transplant or any another inflammatory condition for which treatment cannot be interrupted safely.
- •2. Treated with Rituximab drip in the last 18 months or planning to start it
- •3. Concurrent immune suppressive treatments in the last two months specifically leflunomide, ciclosporin, azathioprine or mercaptopurine, sulfasalazine or other 5-amino-salicylic acid drugs, mycophenolate, apremilast, or biologic agents
- •4. Radiotherapy or cancer chemotherapy in last six months
- •5. Prednisolone dose >7.5 mg/day within 30 days of randomisation
- •6. Active solid organ cancer (people with skin cancer or those cured of solid organ cancer are eligible)
- •Previous participant exclusion criteria:
- •1. Diagnosed with inflammatory conditions for which treatment cannot be interrupted safely such as ANCA associated vasculitis, large vessel vasculitis, myositis, giant cell arteritis, or solid organ transplant
- •2. Treated with Rituximab drip in the last 18 months or planning to start it
- •3. Concurrent immune suppressive treatments in the last two months specifically leflunomide, ciclosporin, azathioprine or mercaptopurine, sulfasalazine or other 5-amino-salicylic acid drugs, mycophenolate, apremilast, or biologic agents
- •4. Radiotherapy or cancer chemotherapy in last six months
- •5. Prednisolone dose >7.5 mg/day within 30 days of randomisation
- •6. Active solid organ cancer (people with skin cancer or those cured of solid organ cancer are eligible)
研究者
相似试验
已完成
不适用
The impact of pausing BTKi therapy and responsiveness of vaccination in blood cancer patients: A randomised controlled study – the IMPROVE studyChronic lymphocytic leukaemiaCancerISRCTN14197181niversity of Birmingham99
进行中（未招募）
不适用
Scaphoid Waist Internal Fixation for Fractures Trial: A trial evaluating cast versus surgical fixation for fractures of the scaphoid waist in adultsMusculoskeletal trauma of the hand and wristMusculoskeletal DiseasesISRCTN67901257niversity Hospitals of Leicester NHS Trust (UK)439
进行中（未招募）
不适用
Spotlight tools to improve routine clinical careISRCTN15511689Southern Health NHS Foundation Trust98
已完成
不适用
A patient and carer shared management intervention for anorexiaMental and Behavioural DisordersAnorexia nervosaISRCTN14644379South London and Maudsley NHS Foundation Trust380
已完成
不适用
The Gentle Years Yoga TrialTwo or more chronic health conditions in people aged over 65 yearsMulti-morbidityISRCTN13567538orthumbria University Newcastle454